Tertiary lymphoid structures predict the prognosis and immunotherapy response of cholangiocarcinoma
2023 · Frontiers in Immunology · 70 citations
https://doi.org/10.3389/fimmu.2023.1166497
Y
Yufei Pan
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
73
Papers
1.2K
Citations
23
h-index
28
i10-index
Yufei Pan is an academic researcher from Guilin Medical University. The author has contributed to research in topics: Cholangiocarcinoma and Gallbladder Cancer Studies & RNA modifications and cancer & Peptidase Inhibition and Analysis. The author has an h-index of 23, co-authored 63 publications.
ORCID: 0000-0001-8978-3029Papers by this author
worksURI alleviates tyrosine kinase inhibitors-induced ferroptosis by reprogramming lipid metabolism in p53 wild-type liver cancers
2023 · Nature Communications · 66 citations
https://doi.org/10.1038/s41467-023-41852-z
The oncoprotein p28GANK establishes a positive feedback loop in β-catenin signaling
2011 · Cell Research · 45 citations
https://doi.org/10.1038/cr.2011.103
Expression of cytoskeleton-associated protein 4 is related to lymphatic metastasis and indicates prognosis of intrahepatic cholangiocarcinoma patients after surgery resection
2013 · Cancer Letters · 31 citations
https://doi.org/10.1016/j.canlet.2013.05.003
A nuclei bombing nano-system improves STING-activated cancer immunotherapy
2025 · Nano Today · 3 citations
https://doi.org/10.1016/j.nantod.2025.102749
Surgical Management Strategies for Carotid Artery Invasion by Head and Neck Cancer: Ligation Versus Reconstruction
2024 · Otolaryngology · 2 citations
https://doi.org/10.1002/ohn.824
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat